Investing in start-ups that will fundamentally change the way cancer care is designed and delivered at scale. @OncoVentures on Twitter
Investment Stage: Series A; Series B
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 19.11.2025 | WellBeam | well-beam.com | $10M | United Sta... |
| 07.11.2025 | Lumonus | lumonus.com | $25M | Australia |
| 28.09.2025 | Daymark He... | daymarkhealth.com | $31.5M | United Sta... |
Mentions in press and media 10
| Date | Title | Description |
| 28.05.2026 | Triomics Secures $22M to Automate Oncology AI Chart Abstraction Beyond the Registry Bottleneck: Why Triomics Raised $22M to Automate Oncology Record Curation | What You Should Know Oncology AI innovator Triomics has announced a $22M Series B financing round led by Battery Ventures, pushing its total venture funding past $36 million. The expansion round features strategic backing from Lightspeed, N... |
| 19.11.2025 | WellBeam Raises $10M Series A to Break EMR Silos Between Acute and Post-Acute Care | What You Should Know: – WellBeam, a healthcare technology company, announced that it has successfully raised $10M in Series A funding led by Wittington Ventures and included participation from F-Prime, Advocate Health, and Oncology Ventures... |
| 08.11.2025 | Lumonus Boosts AI Oncology with $25M Investment for US Expansion | Lumonus, an AI oncology leader, secured $25M in Series B funding. This investment boosts its cutting-edge AI platform globally. It targets US market expansion. The platform automates radiation oncology workflows. It improves cancer treatmen... |
| 07.11.2025 | Lumonus Raises A$25 Million in Series B to Scale AI Powered Oncology Workflows Globally | SYDNEY, Nov. 7, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with conti... |
| 07.11.2025 | Lumonus: A$25 Million Series B Raised To Expand Global AI Oncology Platform | Lumonus has raised A$25 million in a Series B financing round to expand the global reach and product capabilities of its AI-powered radiation oncology workflow platform. The round was led by Aviron Investment Management with continued parti... |
| 29.09.2025 | Daymark Health Secures $20M to Redefine Cancer Care | Daymark Health secured $20M in Series A funding. Healthier Capital and Blue Venture Fund led the round. This investment scales Daymark's value-based cancer care platform. The company revolutionizes cancer treatment, offering integrated supp... |
| 26.09.2025 | Daymark Health Secures $20M to Scale Value-Based Cancer Care | What You Should Know: – Daymark Health, a company dedicated to redefining the cancer care experience secures $20M in Series A funding round led by Healthier Capital and Blue Venture Fund, with continued participation from existing investors... |
| 04.04.2025 | Daymark Health: A New Dawn in Cancer Care | In the world of cancer care, change is often slow. But Daymark Health is here to flip the script. This Philadelphia-based company has just raised $11.5 million in seed funding, a shot in the arm for its ambitious mission. Co-led by Maverick... |
| 03.04.2025 | Daymark Health Launches with $11.5M to Redefine Cancer Care | What You Should Know: – Daymark Health, a company aiming to redefine the cancer care experience, has publicly launched with an $11.5M in seed funding co-led by Maverick Ventures and Yosemite, with additional participation from Oncology Vent... |
| 03.04.2024 | From generative chemistry to computational astrophysics, startups employ new methods to fight cancer | Here are a few startups in the cancer space that made headlines recently The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o... |